# JAVELIN.AI Multi-Agent Analysis Report

**Generated:** 2026-01-28 04:05:54

**Sites Analyzed:** 3

## Agent Architecture

```
┌─────────────────────────────────────────────────────────────┐
│                    COORDINATOR AGENT                         │
│         (Synthesizes insights, resolves conflicts)           │
└─────────────────────────────────────────────────────────────┘
                              ▲
          ┌───────────────────┼───────────────────┐
          │                   │                   │
    ┌─────┴─────┐       ┌─────┴─────┐       ┌─────┴─────┐
    │  SAFETY   │       │   DATA    │       │PERFORMANCE│
    │   AGENT   │       │  QUALITY  │       │   AGENT   │
    │   (40%)   │       │   (35%)   │       │   (25%)   │
    └───────────┘       └───────────┘       └───────────┘
```

## Executive Summary

- **Critical Risk Sites:** 3
- **High Risk Sites:** 0
- **Medium Risk Sites:** 0
- **Escalations Required:** 3

## Portfolio Context

- Total Sites in Portfolio: 3424
- Total Studies: 23
- Portfolio Avg DQI: 0.0504
- Portfolio Avg SAE Pending: 1.90

## Critical Priority Sites (Immediate Action Required)

### Site: Site 888 (Study_24)
- **Risk Category:** Critical
- **Composite Score:** 0.9157
- **Escalation Required:** YES
- **Consensus:** Safety concerns require immediate attention. Data quality issues affecting reliability. Performance below portfolio standards.
- **Key Issues:**
  - CRITICAL: 29 SAE reviews pending
  - Uncoded adverse events: 10
  - Uncoded drug terms: 23
- **Recommended Actions:**
  - Immediate SAE review completion required
  - Escalate to Safety Officer
  - Complete MedDRA coding for adverse events

### Site: Site 17 (Study_1)
- **Risk Category:** Critical
- **Composite Score:** 0.8450
- **Escalation Required:** YES
- **Consensus:** Safety concerns require immediate attention. Data quality issues affecting reliability. Performance below portfolio standards.
- **Key Issues:**
  - CRITICAL: 8 SAE reviews pending
  - Uncoded adverse events: 4
  - SAE rate 4.2x portfolio average
- **Recommended Actions:**
  - Immediate SAE review completion required
  - Escalate to Safety Officer
  - Complete MedDRA coding for adverse events

### Site: Site 27 (Study_1)
- **Risk Category:** Critical
- **Composite Score:** 0.6317
- **Escalation Required:** YES
- **Consensus:** Safety concerns require immediate attention. Performance below portfolio standards.
- **Key Issues:**
  - CRITICAL: 40 SAE reviews pending
  - Uncoded adverse events: 2
  - Uncoded drug terms: 2
- **Recommended Actions:**
  - Immediate SAE review completion required
  - Escalate to Safety Officer
  - Complete MedDRA coding for adverse events


## Action Summary by Domain

### Safety Domain
- Immediate SAE review completion required
- Escalate to Safety Officer
- Complete MedDRA coding for adverse events

### Data Quality Domain
- Urgent: Complete visit documentation
- URGENT: Address long-outstanding missing pages
- Schedule visit data entry
- Complete external data reconciliation

---

*Report generated by JAVELIN.AI Multi-Agent System*